TearCare® system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare® treatment on subjects with dry eye disease
David Badawi Clinical Trials Section, Central Eye Care, Arlington Heights, IL, USA Purpose: Evaluation of the safety and effectiveness of a TearCare® retreatment in adult subjects with clinically significant dry eye disease (DED).Patients and methods: This was an extension of an initial 6-...
Enregistré dans:
| Auteur principal: | Badawi D |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2019
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/f4c4defd4bfd4b3d95369eac936dc06a |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A novel system, TearCare®, for the treatment of the signs and symptoms of dry eye disease
par: Badawi D
Publié: (2018) -
A Prospective, Post-Market, Multicenter Trial (CHEETAH) Suggested TearCare® System as a Safe and Effective Blink-Assisted Eyelid Device for the Treatment of Dry Eye Disease
par: Karpecki P, et autres
Publié: (2020) -
Effect of thermal pulsation treatment on tear film parameters in dry eye disease patients
par: Kim MJ, et autres
Publié: (2017) -
Frequency and risk factors associated with dry eye in patients attending a tertiary care ophthalmology center in Mexico City
par: Martinez JD, et autres
Publié: (2016) -
Effect of topical 3% diquafosol sodium on eyes with dry eye disease and meibomian gland dysfunction
par: Amano S, et autres
Publié: (2017)